Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Enhancing Electronic Health Systems to Decrease the Burden of Colon Cancer, Lung Cancer, Obesity, Vaccine-Preventable Illness, and LivER Cancer (CLOVER)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04540081
Recruitment Status : Recruiting
First Posted : September 7, 2020
Last Update Posted : November 12, 2020
Sponsor:
Collaborator:
University of California, Irvine
Information provided by (Responsible Party):
University of California, Davis

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The purpose of CLOVER is to utilize Epic Healthy Planet to increase adherence to United States Preventive Services Task Force (USPSTF) and Centers for Disease Control and Prevention (CDC) recommendations in adults age 50 and older.

Condition or disease Intervention/treatment Phase
Colon Cancer Lung Cancer Tobacco Use Cessation Obesity Pneumonia, Bacterial Shingles Hepatitis C Other: Epic Healthy Planet Population Health Module Not Applicable

Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 20000 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Enhancing Electronic Health Systems to Decrease the Burden of Colon Cancer, Lung Cancer, Obesity, Vaccine-Preventable Illness, and LivER Cancer
Actual Study Start Date : October 5, 2020
Estimated Primary Completion Date : August 2025
Estimated Study Completion Date : August 2025

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Liver Cancer

Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: CLOVER arm
This arm will contain clinics that utilize the CLOVER intervention
 Other: Epic Healthy Planet Population Health Module
Electronic population health module which is tailored to increased adherence to USPSTF and CDC recommendations
No Intervention: Standard of Care arm
This arm will contain clinics that do not utilize the CLOVER intervention


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Overall Adherence to CLOVER Metrics [ Time Frame: 6 months ]
    This is the proportion of patients who appropriately completed screenings and vaccinations that they were eligible for


Secondary Outcome Measures :
  1. Colon cancer screening [ Time Frame: 6 months ]
    Proportion of eligible patients who completed colon cancer screening.

  2. Lung cancer screening [ Time Frame: 6 months ]
    Proportion of eligible patients who completed lung cancer screening.

  3. Tobacco cessation counseling [ Time Frame: 6 months ]
    Proportion of eligible patients who completed tobacco cessation counseling.

  4. Obesity counseling [ Time Frame: 6 months ]
    Proportion of eligible patients who completed obesity counseling.

  5. Pneumonia vaccination [ Time Frame: 6 months ]
    Proportion of eligible patients who completed pneumonia vaccination.

  6. Shingles vaccination [ Time Frame: 6 months ]
    Proportion of eligible patients who completed shingles vaccination.

  7. Hepatitis C screening [ Time Frame: 6 months ]
    Proportion of eligible patients who completed hepatitis C screening.


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   50 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

- Any patient who has a UC Davis or UC Irvine primary care provider (PCP) and is deficient in any of the following: colon cancer screening, lung cancer screening, tobacco cessation counseling, obesity counseling, pneumonia vaccination, shingles vaccine, and hepatitis C screening.

Exclusion Criteria:

- Patients outside of the age limits or have an established PCP.

Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04540081


Contacts
Layout table for location contacts
Contact: Eric Chak, MD, MPH 916-734-3751 echak@ucdavis.edu

Locations
Layout table for location information
United States, California
UC Davis Medical Center Recruiting
Sacramento, California, United States, 95817
Contact: Eric Chak, MD, MPH    916-734-3751    echak@ucdavis.edu   
Sponsors and Collaborators
University of California, Davis
University of California, Irvine
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: University of California, Davis
ClinicalTrials.gov Identifier: NCT04540081    
Other Study ID Numbers: 1624888
First Posted: September 7, 2020    Key Record Dates
Last Update Posted: November 12, 2020
Last Verified: November 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Pneumonia, Bacterial
Hepatitis C
Lung Neoplasms
Colonic Neoplasms
Liver Neoplasms
Pneumonia
Obesity
Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Neoplasms
Lung Diseases
Respiratory Tract Diseases
Overnutrition
Nutrition Disorders
 Overweight
Body Weight
Hepatitis
Liver Diseases
Digestive System Diseases
Hepatitis, Viral, Human
Virus Diseases
Flaviviridae Infections
RNA Virus Infections
Respiratory Tract Infections
Colorectal Neoplasms
Intestinal Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Gastrointestinal Diseases